Fig. 1 · Structure
Documents & Downloads
Monodes(N-carboxymethyl)valine Daclatasvir
Daclatasvir Degradation Drug
Monodes(N-carboxymethyl)valine Daclatasvir, also known as Daclatasvir Impurity A, is a primary degradation product of the antiviral agent Daclatasvir, which specifically targets the NS5A protein of the Hepatitis C virus (HCV). This compound is utilized in research applications focusing on the stability and degradation pathways of Daclatasvir, helping to understand its pharmacological profile and potential implications in HCV treatment strategies.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 1007884-60-7 |
| Applications | Daclatasvir Degradation Drug |
| Formula | C33H39N7O3 |
| Molecular Weight | 581.71 |
| Synonyms | Daclatasvir Impurity A |
| SMILES | COC(N[C@@H](C(C)C)C(N(CCC1)[C@@H]1C2=NC(C3=CC=C(C4=CC=C(C5=CNC([C@H]6NCCC6)=N5)C=C4)C=C3)=CN2)=O)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.